HIV and Hepatitis.com - HIV-HBV Coinfection

HIV-HBV Coinfection

Hepatitis B Main Section
HIV and AIDS Main Section

----

HIV and Hepatitis.com Coverage of the 15th Conference on Retroviruses and Opportunistic Infections (CROI 2008) February 3 - 6, 2008, Boston, MA

HIV-HBV Coinfection Top New Articles
•	Hepatitis B Coinfection Does Not Interfere with Response to Antiretroviral Therapy - 4/15/08
•	Another Report of Drug-resistant HIV in a Patient Treated with Entecavir (Baraclude) for Hepatitis B - 4/11/08
•	Hepatitis Flares in HIV-HBV Coinfected Patients Starting HAART May Be Due to Immune Restoration - 3/04/08
•	HIV Coinfection Contributes to Mortality Related to Chronic Hepatitis B and C in France - 2/29/08
•	Hepatitis B Coinfection Does Not Impact HIV Suppression or CD4 Cell Recovery on HAART - 2/26/08
•	Two Studies Look at Anti-HIV Activity of Entecavir (Baraclude) - 2/12/08
•	Effect of HAART and Hepatitis B Vaccination on Epidemiology of HIV-HBV Coinfection - 2/05/08
•	HIV Entry into Hepatic Stellate Cells Promotes Liver Fibrosis Progression - 2/05/08
•	HAART Containing Tenofovir (Viread) plus Emtricitabine (Emtriva) Is Effective for HIV-HBV Coinfected Patients, but Treatment Should Not Be Interrupted - 1/11/08
•	Antiretroviral Therapy Improves Poor Prognosis among HIV-HCV and HIV-HBV Coinfected Patients with Liver Cirrhosis - 12/14/07
•	Studies Look at Triple or Quadruple Infection with HBV, HCV, and HDV in HIV Positive Individuals - 12/11/07
•	Liver Enzyme Elevation and Immune Reconstitution in HIV Patients with and without Hepatitis B or C Coinfection - 12/07/07
•	HIV-HBV Coinfected Liver Transplant Recipients Have Outcomes Similar to Those of HIV Negative Patient
•	Hepatitis B Serological Markers May Change over Time in HIV-HBV Coinfected Individuals on Antiretroviral Therapy - 10/19/07
•	Mutations Associated with Lamivudine (3TC; Epivir) Resistance in Previously Untreated Hepatitis B Patients with and without HIV - 10/12/07
•	Good Response to Hepatitis B Treatment Is Associated Sustained Response to Antiretroviral Therapy in HIV-HBV Coinfected Patients - 9/25/07
•	Bristol-Myers Squibb Warns Providers about Anti-HIV Activity of Entecavir (Baraclude) in HIV-HBV Coinfected Patients - 8/21/07
•	Presence of Mixed Hepatitis B Genotypes Occurs More Frequently in HIV-HBV Coinfected Patients - 8/17/07
•	Liver Disease and Survival Outcomes in HIV-HBV Coinfected Individuals - 8/17/07
•	Safety of Atazanavir (Reyataz) in HIV-HBV and HIV-HCV Coinfected Patients with Pre-existing Liver Disease - 8/10/07
•	Hepatitis B Virus and HIV Coinfection: Results of a Survey on Treatment Practices and Recommendations for Therapy - 8/10/07
•	HIV Positive Individuals More Likely to Respond to High-dose HBV Vaccine - 8/03/07
•	Complete HBV Genome Analysis in HIV Coinfected Individuals Identifies a Novel Core/precore Mutant - 8/03/07
•	HAART Regimens Containing Tenofovir (Viread) or Lamivudine (Epivir) in HIV-HBV Coinfected Patients - 7/31/07
•	Impact of Antiretroviral Treatment Interruption among HIV-HCV and HIV-HBV Coinfected Patients in the SMART Trial - 7/31/07
•	Liver Toxicity Among HIV Positive African Patients on HAART is Associated with Tuberculosis Therapy and Hepatitis B Coinfection - 7/07/07
•	Epidemiology, Diagnosis, and Treatment of Chronic Hepatitis B in HIV Positive Patients - 7/03/07
•	Experimental HBV Drug Clevudine Shows Promise at the XVI International HIV Drug Resistance Workshop in Barbados - 6/19/07
•	When HIV and Liver Disease Co-exist - 6/12/07
•	Hepatitis Delta Infection May Worsen Disease Progression in HIV-HBV Coinfected Individuals - 5/25/07
•	Revised Treatment Guidelines for Use of Entecavir in HIV-HBV Coinfected Patients - 5/11/07
•	HAART Regimens Containing Tenofovir Plus Lamivudine or Emtricitabine Work Best for HIV-HBV Coinfected Patients - 5/01/07
•	Role of HIV Coinfection in Mortality Related to Hepatitis B or C - 4/24/07
•	Do HIV Care Providers Appropriately Manage Hepatitis B in Coinfected Patients? - 4/10/07
•	HBV Less Likely than HCV to Cause Liver Disease Progression and Death in People with HIV - 4/06/07
•	Treatment of Chronic Hepatitis B or C in HIV Positive Patients with Triple Infection - 4/3/07
•	Emergence of Tenofovir-resistant Mutations Is Uncommon in HIV-HBV Coinfected Patients - 4/3/07
•	Hepatitis B Virus Kinetics and Treatment Response in HIV-HBV Coinfected Patients - 3/30/07
•	Long-term Lamivudine plus Tenofovir Is Safe and Effective in HIV-HBV Coinfected Patients - 3/27/07
•	HBV Vaccination in HIV Positive People 3/20/07
•	Outcomes in HIV-HBV Coinfected Patients Treated with Drugs Active Against Both Viruses 10/17/06
•	Safety of Atazanavir in Patients with HIV/HCV or HIV/HBV Coinfection 9/12/06
•	Response to Antiretroviral Therapy and Survival in HIV/HCV and HIV/HBV Coinfected Patients in Asia - 8/25/06
•	Impact of Occult HBV in HIV Positive Patients - 8/15/06
•	Preventing HBV Recurrence in HIV/HBV Coinfected Patients Undergoing Liver Transplantation - 8/01/06
•	Recommendations for Management of Chronic Hepatitis B and C in HIV Coinfected Patients - 4/18/06
•	Tenofovir Therapy Appears to Be the Best Current Option for Treatment of HBV in HIV-coinfected Patients - 2/24/06
•	The Impact of HAART on Treatment of HIV-HCV and HIV-HBV Coinfection - 2/21/06
•	Is Combination Therapy More Effective Than Monotherapy for Chronic HBV in HIV-coinfected Patients? - 2/21/06
•	Low Incidence of Resistance to Entecavir after 48 Weeks of Treatment in HIV-HBV Coinfected Patients - 2/21/06
•	Survival Outcomes among HIV-HBV Coinfected Patients on HAART - 2/21/06
•	How Common Is Occult HBV Infection in HIV Coinfected Patients? - 2/21/06
•	HBV Vaccination in HIV Patients - 2/21/06
•	Hepatitis Delta Virus Worsens the Outcome of HBV-HIV Coinfected Patients - 2/21/06
•	4-year Outcome of Liver Transplantation in HIV Patients - 2/21/06

Website Sponsors

FDA-approved Hepatitis B Treatments

Baraclude (entecavir)
Epivir-HBV (lamivudine; 3TC)
Intron A (interferon alfa-2b)
Hepsera (adefovir dipivoxil)
Pegasys (peginterferon alfa-2a)
Tyzeka (telbivudine)

FDA-approved HIV and
AIDS Treatments

Protease Inhibitors